Evidence map›Paper›PMID 23551462›Full record

ReviewWound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society

Neutrophil activity in chronic venous leg ulcers--a target for therapy?

Jodi C McDaniel, Sashwati Roy, Traci A Wilgus

Registry-linked trialAbstract readReview
In one paragraph

Review in Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04507724 (The Use of Biochemical Analyzes to Monitor the Development of Wounds), which is not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04507724 completednot on this map

The Use of Biochemical Analyzes to Monitor the Development of Wounds: Part 1: Analysis of Wounds Without VAC Therapy: Part 2: Analysis of Wound Fluids Under VAC Therapy

TypeobservationalSponsorQualizyme Diagnostics GmbH & Co KGRan2018 to 2020Enrolled41ConditionsWound, Wound Infection, Wound Contamination, Diagnostic Techniques and Procedures
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Skin-Derived ABCB5International journal of molecular sciences · 2022
    Review
  7. Review
  8. Review
  9. Nanomaterial-Based Therapy for Wound Healing.Nanomaterials (Basel, Switzerland) · 2022
    Review
  10. Recent Advances in Nanozymes for Bacteria-Infected Wound Therapy.International journal of nanomedicine · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jodi C McDanielCollege of Nursing, The Ohio State University, Columbus, Ohio 43210, USA. mcdaniel.561@osu.edu
Sashwati Roy
Traci A Wilgus
The Ohio State University · US

Funding

University of Iowa Clinical and Translational Science Program (TL1)UL1RR025755 · NCRR · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2008 to 2011
$26.3M
Keratinocyte responses to vascular endothelial growth factor in carcinogenesisR01CA127109 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI WILGUS, TRACI A · 2007 to 2012
$1.4M
Mechanisms underlying impaired diabetic wound healingR01DK076566 · NIDDK · OHIO STATE UNIVERSITY · PI ROY, SASHWATI · 2008 to 2011
$1.2M
Mast cells and immunosuppression in skin cancerR21ES020462 · NIEHS · OHIO STATE UNIVERSITY · PI WILGUS, TRACI A · 2012 to 2013
$416k
NCI NIH HHS CA127109NCI NIH HHS R01 CA127109NCRR NIH HHS UL1 RR025755NCRR NIH HHS UL1RR025755NIDDK NIH HHS R01 DK076566NIEHS NIH HHS ES020462NIEHS NIH HHS R21 ES020462
6 · The paper itself

Abstract

Chronic venous leg ulcers (CVLUs) affect approximately 600,000 people annually in the United States and accrue yearly treatment costs of US $2.5-5 billion. As the population ages, demands on health care resources for CVLU treatments are predicted to drastically increase because the incidence of CVLUs is highest in those ≥65 years of age. Furthermore, regardless of current standards of care, healing complications and high recurrence rates prevail. Thus, it is critical that factors leading to or exacerbating CVLUs be discerned and more effective, adjuvant, evidence-based treatment strategies be utilized. Previous studies have suggested that CVLUs' pathogenesis is related to the prolonged presence of high numbers of activated neutrophils secreting proteases in the wound bed that destroy growth factors, receptors, and the extracellular matrix that are essential for healing. These events are believed to contribute to a chronically inflamed wound that fails to heal. Therefore, the purpose of this project was to review studies from the past 15 years (1996-2011) that characterized neutrophil activity in the microenvironment of human CVLUs for new evidence that could explicate the proposed relationship between excessive, sustained neutrophil activity and CVLUs. We also appraised the strength of evidence for current and potential therapeutics that target excessive neutrophil activity.

Indexed as

Wound HealingChronic DiseaseHumansNegative-Pressure Wound TherapyNeutrophil ActivationNeutrophilsPeptide HydrolasesProtease InhibitorsVaricose UlcerPeptide HydrolasesProtease Inhibitors

Identifiers

PMID23551462
PMCPMC3795526
OpenAlexW1523617147

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.